Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
1R01DE012162-01
Application #
2331343
Study Section
Special Emphasis Panel (ZDE1-YS (31))
Project Start
1996-09-30
Project End
2001-07-31
Budget Start
1996-09-30
Budget End
1997-07-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
University of North Carolina Chapel Hill
Department
Dentistry
Type
Schools of Dentistry
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599

  Publications

Chattopadhyay, Amit; Gray, Laurie R; Patton, Lauren L et al. (2004) Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons. Infect Immun 72:1956-63
Gray, Laurie R; Alexander, Audrey L; Shugars, Diane C (2002) Construction, non-denaturing affinity purification, and characterization of baculovirally expressed human secretory leukocyte protease inhibitor. Protein Expr Purif 26:179-86
Freel, S A; Williams, J M; Nelson, J A et al. (2001) Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. J Virol 75:4936-40
Shugars, D C; Slade, G D; Patton, L L et al. (2000) Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89:432-40
Shugars, D C; Wahl, S M (1998) The role of the oral environment in HIV-1 transmission. J Am Dent Assoc 129:851-8
McNeely, T B; Shugars, D C; Rosendahl, M et al. (1997) Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 90:1141-9